Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.16
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. The company is headquartered in Jericho, New York.
See the full interactive analysis & chart →Informational only — not investment advice.